Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial

Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton C, Distler J, Hoffmann-Vold AM, Khanna D, Mayes M, Raghu G, Vonk M, Gahlemann M, Girard M, Stowasser S, Zoz D, Fischer A, Maher T (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Involved external institutions

Cleveland Clinic United States (USA) (US) Universitätsspital Zürich (USZ) Switzerland (CH) Nippon Medical School Japan (JP) University of Montpellier / Université Montpellier France (FR) University College London (UCL) United Kingdom (GB) Oslo University Hospital / Oslo Universitetssykehus Rikshospitalet Norway (NO) University of Michigan United States (USA) (US) University of Paris 5 - René Descartes / Université Paris V René Descartes France (FR) University of Texas MD Anderson Cancer Center United States (USA) (US) University of Washington United States (USA) (US) Radboud University Nijmegen Netherlands (NL) Boehringer Ingelheim Schweiz Switzerland (CH) Boehringer Ingelheim (France) France (FR) Boehringer Ingelheim Pharma GmbH & Co. KG Germany (DE) University of Colorado System United States (USA) (US) Imperial College London / The Imperial College of Science, Technology and Medicine United Kingdom (GB)

How to cite

APA:

Highland, K., Distler, O., Kuwana, M., Allanore, Y., Assassi, S., Azuma, A.,... Maher, T. (2019). Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Highland, Kristin, et al. "Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2019.

BibTeX: Download